Acusphere Competitors

Affymax (OTCMKTS:AFFY) and Acusphere (OTCMKTS:ACUS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

Profitability

This table compares Affymax and Acusphere's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares Affymax and Acusphere's gross revenue, earnings per share and valuation.

Risk & Volatility

Affymax has a beta of 2.77, meaning that its share price is 177% more volatile than the S&P 500. Comparatively, Acusphere has a beta of -0.25, meaning that its share price is 125% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Affymax and Acusphere, as reported by MarketBeat.com.

Summary

Affymax beats Acusphere on 1 of the 1 factors compared between the two stocks.

ARYx Therapeutics (OTCMKTS:ARYX) and Acusphere (OTCMKTS:ACUS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

Profitability

This table compares ARYx Therapeutics and Acusphere's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares ARYx Therapeutics and Acusphere's gross revenue, earnings per share and valuation.

Risk & Volatility

ARYx Therapeutics has a beta of -0.53, meaning that its share price is 153% less volatile than the S&P 500. Comparatively, Acusphere has a beta of -0.25, meaning that its share price is 125% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for ARYx Therapeutics and Acusphere, as reported by MarketBeat.com.

Summary

Acusphere beats ARYx Therapeutics on 1 of the 1 factors compared between the two stocks.

AtheroNova (OTCMKTS:AHROQ) and Acusphere (OTCMKTS:ACUS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

Risk & Volatility

AtheroNova has a beta of -8.71, meaning that its share price is 971% less volatile than the S&P 500. Comparatively, Acusphere has a beta of -0.25, meaning that its share price is 125% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for AtheroNova and Acusphere, as reported by MarketBeat.com.

Profitability

This table compares AtheroNova and Acusphere's net margins, return on equity and return on assets.

Valuation & Earnings

This table compares AtheroNova and Acusphere's gross revenue, earnings per share and valuation.

Summary

Acusphere beats AtheroNova on 1 of the 1 factors compared between the two stocks.

Acusphere (OTCMKTS:ACUS) and China Botanic Pharmaceutical (OTCMKTS:CBPI) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.

Risk and Volatility

Acusphere has a beta of -0.25, meaning that its stock price is 125% less volatile than the S&P 500. Comparatively, China Botanic Pharmaceutical has a beta of 17.09, meaning that its stock price is 1,609% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations for Acusphere and China Botanic Pharmaceutical, as reported by MarketBeat.

Profitability

This table compares Acusphere and China Botanic Pharmaceutical's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Acusphere and China Botanic Pharmaceutical's gross revenue, earnings per share and valuation.

Summary

China Botanic Pharmaceutical beats Acusphere on 1 of the 1 factors compared between the two stocks.

Acusphere (OTCMKTS:ACUS) and China Dongsheng International (OTCMKTS:CDSG) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.

Risk and Volatility

Acusphere has a beta of -0.25, meaning that its stock price is 125% less volatile than the S&P 500. Comparatively, China Dongsheng International has a beta of 13.38, meaning that its stock price is 1,238% more volatile than the S&P 500.

Profitability

This table compares Acusphere and China Dongsheng International's net margins, return on equity and return on assets.

Valuation and Earnings

This table compares Acusphere and China Dongsheng International's gross revenue, earnings per share and valuation.

Analyst Ratings

This is a breakdown of recent recommendations for Acusphere and China Dongsheng International, as reported by MarketBeat.

Summary

China Dongsheng International beats Acusphere on 1 of the 1 factors compared between the two stocks.

Acusphere (OTCMKTS:ACUS) and China Health Industries (OTCMKTS:CHHE) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, profitability and risk.

Risk & Volatility

Acusphere has a beta of -0.25, meaning that its stock price is 125% less volatile than the S&P 500. Comparatively, China Health Industries has a beta of 1.67, meaning that its stock price is 67% more volatile than the S&P 500.

Profitability

This table compares Acusphere and China Health Industries' net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Acusphere and China Health Industries' revenue, earnings per share (EPS) and valuation.

China Health Industries has higher revenue and earnings than Acusphere.

Analyst Recommendations

This is a breakdown of recent ratings for Acusphere and China Health Industries, as reported by MarketBeat.

Summary

China Health Industries beats Acusphere on 5 of the 5 factors compared between the two stocks.